Top Markets
#1 Official Trump Official Trump +31.38%
#2 Tutorial Tutorial +28.82%
#3 Siacoin Siacoin +22.34%
#4 Mubarak Mubarak +21.04%
#5 Melania Meme Melania Meme +19.92%
#6 Unit Pump Unit Pump +19.37%
#7 Pump.fun Pump.fun +19.37%
#8 EXOD EXOD +18.93%
#9 MowCat MowCat +18.85%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +17.57%
Coin of the day
Official Trump Official Trump
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Classement en actions #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
Prix de l'action
$20.65
Dernière synchronisation: 2023-03-01
Capitalisation boursière
$82.52M
Changement (1 jour)
-0.58%
Changement (1 an)
0.00%
Pays
US
Échange Opiant Pharmaceuticals, Inc. (OPNT)

Catégorie

Healthcare
Bénéfices pour Opiant Pharmaceuticals, Inc. (OPNT)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Opiant Pharmaceuticals, Inc., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Opiant Pharmaceuticals, Inc. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH